When accessing the CDB site through an internal Novo Nordisk IP address, you will see "Your Location" as NN Internal instead of a country. This only applies to internal NN IP addresses. Thank you for your patience while the development team is upgrading this feature.

Your Location: USA

Help Join the Cause Submit Data

Bookmark and Share

Diabetes Facts

Return To Top

Costs to Society

The costs of diabetes affects you, me, and future generations

Find Out How

See How Your Country Measures Up

Get diabetes data in four key areas: Quality of Care, Prevalence of Diabetes, Cost of Diabetes, and Access to Care

Diabetes Data

The Barometer Report

Learn about the history and objectives of Changing Diabetes Barometer

Read the Barometer Report

References:
1. International Diabetes Federation. Diabetes and impaired glucose tolerance. In: The Diabetes Atlas. Fourth Edition Brussels: International Diabetes Federation; 2009.
2. International Diabetes Federation. Prevalence estimates of diabetes mellitus, 2010. In: The Diabetes Atlas. Fourth Edition Brussels: International Diabetes Federation; 2009.
3. International Diabetes Federation. Prevalence estimates of diabetes mellitus, 2030. In: The Diabetes Atlas. Fourth Edition Brussels: International Diabetes Federation; 2009.
4. International Diabetes Federation. The economic impacts of diabetes. In: The Diabetes Atlas. Fourth Edition. Brussels: International Diabetes Federation; 2009.
5. Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care. 2005;28:2130-2135.
6. Yach D, Hawkes C, Gould CL, Hofman K. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA. 2004;291:2616-2622.
7. International Diabetes Federation. Foreword. In: The Diabetes Atlas. Fourth Edition. Brussels: International Diabetes Federation; 2009.
8. Stratton IM, Adler AI, Neil HA et al., for the United Kingdom Prospective Diabetes Study Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321(7258): 405-412.
9. International Diabetes Federation. World Diabetes Day Media Kit. Brussels: International Diabetes Federation.
10. International Diabetes Federation. Diabetes and impaired glucose tolerance [background paper]. In: The Diabetes Atlas. Fourth Edition Brussels: International Diabetes Federation; 2009.
11. International Diabetes Federation. What is diabetes. In: The Diabetes Atlas. Fourth Edition Brussels: International Diabetes Federation; 2009.
12. International Diabetes Federation. Morbidity and mortality. In: The Diabetes Atlas. Fourth Edition Brussels: International Diabetes Federation; 2009.
13. International Diabetes Federation. Diabetes. In: The Diabetes Atlas. Fourth Edition Brussels: International Diabetes Federation; 2009.
14. International Diabetes Federation. The prevention of type 2 diabetes. In: The Diabetes Atlas. Fourth Edition Brussels: International Diabetes Federation; 2009.
15. International Diabetes Federation. Beyond access to insulin [background paper]. In: The Diabetes Atlas. Fourth Edition Brussels: International Diabetes Federation; 2009.
16. International Diabetes Federation. The economic impacts of diabetes [background paper]. In: The Diabetes Atlas. Fourth Edition Brussels: International Diabetes Federation; 2009.
17. International Diabetes Federation. Summary Table. In: The Diabetes Atlas. Fourth Edition. Brussels: International Diabetes Federation; 2009.

Return To Top